Re: Prostate-specific Antigen Screening for Prostate Cancer and the Risk of Overt Metastatic Disease at Presentation: Analysis of Trends Over Time
- 1 January 2013
- journal article
- editorial
- Published by Elsevier in European Urology
- Vol. 63 (1) , 179
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)European Urology, 2012
- The prostate cancer conundrum revisitedCancer, 2012
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-upJNCI: Journal of the National Cancer Institute, 2012
- Mortality results from the Göteborg randomised population-based prostate-cancer screening trialThe Lancet Oncology, 2010